Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Stomach cancer statistics
New cases of stomach cancer, 2015, UK
Deaths from stomach cancer, 2016, UK
Survive stomach cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of stomach cancer, UK
- There are around 6,900 new stomach cancer cases in the UK every year, that's 19 every day (2013-2015).
- Stomach cancer is the 17th most common cancer in the UK, accounting for 2% of all new cancer cases (2015).
- In males in the UK, stomach cancer is the 13th most common cancer, with around 4,400 new cases in 2015.
- In females in the UK, stomach cancer is the 18th most common cancer, with around 2,400 new cases in 2015.
- Incidence rates for stomach cancer in the UK are highest in people aged 85 to 89 (2013-2015).
- Since the early 1990s, stomach cancer incidence rates have decreased by half (50%) in the UK. Rates in males have decreased by more than half (52%), and rates in females have decreased by around half (49%).
- Over the last decade, stomach cancer incidence rates have decreased by more than a quarter (29%) in the UK. Rates in males have decreased by almost a third (31%), and rates in females have decreased by more than a quarter (28%).
- Around 7 in 10 stomach cancer cases are diagnosed at a late stage in England (2014), Scotland (2014) and Northern Ireland (2010-2014).
- Most stomach cancers occur in the cardia.
- Incidence rates for stomach cancer are projected to fall by 17% in the UK between 2014 and 2035, to 11 cases per 100,000 people by 2035.
- 1 in 67 men and 1 in 135 women will be diagnosed with stomach cancer during their lifetime.
- Stomach cancer in England is more common in people living in the most deprived areas.
- Stomach cancer is most common in Black people, then White people, and least common in Asian people.
- An estimated 18,500 people who had previously been diagnosed with stomach cancer were alive in the UK at the end of 2010.
- In Europe, more than 139,000 new cases of stomach cancer were estimated to have been diagnosed in 2012. The UK incidence rate is fifth lowest in Europe for males and fourth lowest for females.
- Worldwide, more than 951,000 people were diagnosed with stomach cancer in 2012, with incidence rates varying across the world.
- There are around 4,500 stomach cancer deaths in the UK every year, that's 12 every day (2014-2016).
- Stomach cancer is the 14th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2016).
- In males in the UK, stomach cancer is the 11th most common cause of cancer death, with around 2,900 deaths in 2016.
- In females in the UK, stomach cancer is the 15th most common cause of cancer death, with around 1,600 deaths in 2016.
- Mortality rates for stomach cancer in the UK are highest in people aged 85 to 89 (2014-2016).
- Since the early 1970s, stomach cancer mortality rates have decreased by around four-fifths (79%) in the UK. Rates in males have decreased by almost four-fifths (78%), and rates in females have decreased by more than four-fifths (82%).
- Over the last decade, stomach cancer mortality rates have decreased by around a third (32%) in the UK. Rates in males have decreased by a third (33%), and rates in females have decreased by around a third (34%).
- Mortality rates for stomach cancer are projected to fall by 27% in the UK between 2014 and 2035, to 7 deaths per 100,000 people by 2035.
- Stomach cancer deaths in England are more common in people living in the most deprived areas.
- In Europe, more than 107,000 people were estimated to have died from stomach cancer in 2012. The UK mortality rate is seventh lowest in Europe for males and fourth lowest for females.
- Worldwide, around 723,000 people were estimated to have died from stomach cancer in 2012, with mortality rates varying across the world.
- 3 in 20 (15%) people diagnosed with stomach cancer in England and Wales survive their disease for ten years or more (2010-11).
- Around a fifth (19%) of people diagnosed with stomach cancer in England and Wales survive their disease for five years or more (2010-11).
- More than 4 in 10 (42%) of people diagnosed with stomach cancer in England and Wales survive their disease for one year or more (2010-11).
- Stomach cancer survival is higher in men than women at one-year, but similar at five- and ten-years.
- Around a third of people in England diagnosed with stomach cancer aged 15-39 survive their disease for five years or more, compared with around a tenth of people diagnosed aged 80 and over (2009-2013).
- Stomach cancer survival is improving and has almost tripled in the last 40 years in the UK.
- In the 1970s, around 5 in 100 people diagnosed with stomach cancer survived their disease beyond ten years, now it's 3 in 20.
- Five-year relative survival for stomach cancer in men and women is below the European average in England, Wales, Scotland and Northern Ireland.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 54% of stomach cancer cases in the UK are preventable.
- 'Emergency presentation' is the most common route to diagnosing stomach cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
- 22% of patients diagnosed with stomach cancer have surgery to remove the tumour as part of their primary cancer treatment.
- 11% of patients diagnosed with stomach cancer have radiotherapy as part of their primary cancer treatment.
- 35% of patients diagnosed with stomach cancer have chemotherapy as part of their primary cancer treatment.
The latest statistics available for stomach cancer in the UK are; incidence 2015, mortality 2016 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Generally, the studies cited in our risk factors section are on stomach
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Stomach cancer is part in the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.